RNA-Seq to impact future Colorectal Cancer (CRC) Treatment

RNA-Seq to impact future Colorectal Cancer (CRC) Treatment

Enzo Medico, MD, PhD, Associate Professor, University of Torino, School of Medicine, Candiolo Cancer Institute
Topic: Cancer Genomics

Recent studies on colorectal cancer (CRC) have elucidated four CRC consensus molecular subtypes with potential to predict outcome and stratify patients for therapy. Oncogenomics research by Enzo Medico, MD, PhD, from Candiolo Cancer Institute in Torino, describes how his laboratory is using integrative genomic techniques in cancer research to transform the future of CRC therapy.



There are no related events.